Videos

Jeff Stark, MD, discusses how ICD-10 codes for nr-ax-SpA affect patients and providers.

TeleECHO educational programs for healthcare providers have successfully trained physicians and other healthcare providers to fulfill the unmet needs of patients without access to specialty care, particularly osteoporosis care. In this interview with Dr. Michael Lewiecki, he introduces us to Bone Health TeleECHO. He tells us how the program works, why it’s needed and how you can launch one in your state.

Jeff Stark, MD, discusses why nr-ax-SpA wasn't indexed and the process of having it included as an ICD-10 code.

With nr-ax-SpA newly identified as an ICD-10 code, Jeff Stark, MD, discusses why this is so important for patients and clinicians alike.

In this week's news roundup from Rheumatology Network, we feature a one-on-one interview with Dr. Michael Lewiecki of the New Mexico Clinical Research and Osteoporosis Center. He heads a virtual learning program called Bone Health TeleECHO and in this interview, he tells us how the program works, why it’s needed and how you, as a physician, can launch one in your state.

In this week's news roundup and one-on-one interview, we talk with Dr. Daniel Solomon of Brigham and Women’s Hospital and editor-in-chief of the journal Arthritis and Rheumatology. Dr. Solomon and colleagues recently published a commentary called “The Infodemic of COVID-19” in which they break down the inundation of new science on hydroxychloroquine and the cytokine storm.

In this week’s news roundup from Rheumatology Network, we highlight our most popular stories of the week including a one-on-one discussion with Dr. Vibeke Strand, a rheumatologist, immunologist and biopharmaceutical consultant who has conducted clinical trials on JAK inhibitors for rheumatoid arthritis. In this interview, Dr. Strand discusses this and other treatments in development for rheumatoid arthritis.